diethylnitrosamine has been researched along with lactoferrin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brightman, AO; Bruno, M; Lawrence, J; Morre, DJ; Morré, DM; Werderitsh, D | 1 |
Fujita, K; Iigo, M; Ohnishi, T; Sekine, K; Tsuda, H | 1 |
El-Beih, NM; Mohammed, MM; Ramadan, G; Zoheiry, MK | 1 |
Abdelmoneem, MA; Abdulkader, MA; Elkhodairy, KA; Elnaggar, MA; Elzoghby, AO; Fang, JY; Hammady, RS; Helmy, MW; Kamel, SM; Zaky, A | 1 |
Abdel-Rahman, RF; Hassan, AM; Hegazy, RR; Mansour, DF; Salama, AA | 1 |
5 other study(ies) available for diethylnitrosamine and lactoferrin
Article | Year |
---|---|
Stimulation of NADH oxidase activity from rat liver plasma membranes by growth factors and hormones is decreased or absent with hepatoma plasma membranes.
Topics: Animals; Cell Membrane; Cell Separation; Diethylnitrosamine; Epidermal Growth Factor; Glucagon; Growth Substances; Hormones; Insulin; Kinetics; Lactoferrin; Liver; Liver Neoplasms, Experimental; Male; Multienzyme Complexes; NADH, NADPH Oxidoreductases; Rats; Rats, Inbred F344; Vasopressins | 1992 |
Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats.
Topics: Animals; Anticarcinogenic Agents; Blotting, Northern; Blotting, Western; Carcinogens; Cattle; Colon; Colonic Neoplasms; Cytochrome P-450 CYP1A2; Diethylnitrosamine; DNA Adducts; Down-Regulation; Glutathione Transferase; Lactoferrin; Liver; Liver Neoplasms; Male; Polymerase Chain Reaction; Quinolines; Rats; Rats, Inbred F344; RNA, Messenger; Time Factors | 2002 |
Antihepatocarcinogenic activity of whey protein concentrate and lactoferrin in diethylnitrosamine-treated male albino mice.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Cattle; Diethylnitrosamine; Dose-Response Relationship, Drug; Lactoferrin; Liver; Liver Neoplasms, Experimental; Male; Mice; Whey Proteins | 2019 |
Dual-Targeted Lactoferrin Shell-Oily Core Nanocapsules for Synergistic Targeted/Herbal Therapy of Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Diethylnitrosamine; Disaccharides; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Glycyrrhetinic Acid; Hep G2 Cells; Humans; Ki-67 Antigen; Lactoferrin; Liver Neoplasms; Mice; Nanocapsules; NF-kappa B; Phytotherapy | 2019 |
Regulation of PKB/Akt-pathway in the chemopreventive effect of lactoferrin against diethylnitrosamine-induced hepatocarcinogenesis in rats.
Topics: Alanine Transaminase; Animals; Anticarcinogenic Agents; Aspartate Aminotransferases; Cell Proliferation; Chemoprevention; Diethylnitrosamine; Lactoferrin; Liver; Liver Function Tests; Liver Neoplasms, Experimental; Male; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction | 2019 |